fda bpc-157 warning illegal peptide 2025 september The Hidden Risks of BPC‑157: What Patients Need Gray market peptides blur drug
Description
Rights and permissions Open Access This article is published under license to BioMed Central Ltd
Appearance: White to off-white lyophilised powder
It is also used to treat peripheral neuropathy, anemia, and nerve damage related to conditions such as diabetes, alcoholism, or malabsorption syndromes
I had a bout of severe anemia ten years ago, that the lab thought was P.A
